139 related articles for article (PubMed ID: 10452107)
1. Basic fibroblast growth factor enhanced LAK cell cytotoxicities against human bladder neoplasm cells.
Wang ZP; Duan GL; Chen YR; Qin DS; Liu GD; Niu HG
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):276-8. PubMed ID: 10452107
[TBL] [Abstract][Full Text] [Related]
2. Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro.
Wang ZP; Zheng RL; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):522-4. PubMed ID: 10322910
[TBL] [Abstract][Full Text] [Related]
3. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
Wang ZP; Chen YR; Zheng RL; Lu JZ; Wang JJ
Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852
[TBL] [Abstract][Full Text] [Related]
4. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
[TBL] [Abstract][Full Text] [Related]
5. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
Wang Z; Cheng Y; Zheng R; Qin D; Liu G
Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
[TBL] [Abstract][Full Text] [Related]
6. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
Hermann GG; Zeuthen J; Claësson MH
Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of prostaglandin E2 or indomethacin on the proliferation of lymphokine-activated killer cells and their cytotoxicity against bladder tumor cells in patients with bladder cancer.
Wang Z; Chen Y; Zheng R; Qin D; Chen X; Wang Y; Liu G
Prostaglandins; 1997 Nov; 54(5):769-79. PubMed ID: 9491207
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
9. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
Hermann GG; Petersen KR; Steven K; Zeuthen J
J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
[TBL] [Abstract][Full Text] [Related]
10. LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.
Shemtov MM; Cheng DL; Kong L; Shu WP; Sassaroli M; Droller MJ; Liu BC
J Urol; 1995 Jul; 154(1):269-74. PubMed ID: 7776443
[TBL] [Abstract][Full Text] [Related]
11. [The effect of MPS on LAK cell growth and its cytotoxic activity against laryngeal cancer (HEP-2)].
Wang J; Zhu X; Chen J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):283-6. PubMed ID: 9642362
[TBL] [Abstract][Full Text] [Related]
12. Fibrin coating of bladder tumor cells (T24) is not protective against LAK cell cytotoxicity.
Carr ME; Sajer SA; Spaulding A
J Lab Clin Med; 1992 Feb; 119(2):132-8. PubMed ID: 1740625
[TBL] [Abstract][Full Text] [Related]
13. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
[TBL] [Abstract][Full Text] [Related]
15. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line.
Allen LE; Maher PA
J Cell Physiol; 1993 May; 155(2):368-75. PubMed ID: 8387074
[TBL] [Abstract][Full Text] [Related]
16. Ability of lymphokine-activated killer cells to lyse mycobacteria-infected cells.
Chiplunkar SV; Deshmukh MA; Kode JA; Gangal SG; Deo MG
Acta Leprol; 1997; 10(4):203-8. PubMed ID: 9447253
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP
Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
Kaasinen ES; Harju LM; Timonen TT
J Urol; 2002 May; 167(5):2209-14. PubMed ID: 11956480
[TBL] [Abstract][Full Text] [Related]
19. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
[TBL] [Abstract][Full Text] [Related]
20. IL-12 and IL-2 potentiate the in vitro tumor-specific activity of peripheral blood cells from cervical cancer patients.
Verma V; Sharma V; Shrivastava SK; Nadkarni JJ
J Exp Clin Cancer Res; 2000 Sep; 19(3):367-74. PubMed ID: 11144531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
